Search
Search Results
##search.searchResults.foundPlural##
-
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
3529PDF: 2096HTML: 7585 -
T-LYMPHOCYTES EXPRESSION OF TOLL-LIKE RECEPTORS 2 AND 4 IN ACUTE MYELOID LEUKEMIA PATIENTS WITH INVASIVE FUNGAL INFECTIONS Toll-like receptors 2 and 4 in Acute Myeloid Leukemia Patients with Invasive Fungal Infections
1949PDF: 812HTML: 581 -
-
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1446PDF: 504HTML: 18637Figure 1: 207Figure 2: 191Figure 3: 206Figure 4: 239Figure 5: 212 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2334PDF: 1712HTML: 736 -
WHAT UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA TAUGHT US ABOUT TRANSPLANT IMMUNOGENETICS.
3316PDF: 1205HTML: 1696Untitled: 226Untitled: 228Untitled: 215 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2715PDF: 877HTML: 5393 -
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1850PDF: 1396HTML: 670 -
Follicular Lymphoma: A Clinicopathological Analysis from a Tertiary care Institute in Southern India
3604PDF: 862HTML: 3034Figure 1a and 1b: 201Figure 2: 211Figure 3: 218Figure 4: 209Figure 5: 205Tables 1-5: 185 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
5948PDF: 1611HTML: 1678Untitled: 284 -
TARGETING DORMANT BACILLI TO FIGHT TUBERCULOSIS
3226PDF: 1086HTML: 3241 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
2668PDF: 1270HTML: 1095 -
EVALUATION OF THE PLASMA MICRO RNA EXPRESSION LEVELS IN SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
1498PDF: 763HTML: 1193Untitled: 227Untitled: 195Untitled: 183Untitled: 197Untitled: 210 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1729HTML: 708PDF: 925 -
THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone
2720PDF: 1679HTML: 731 -
THE SPECTRUM OF GENETIC DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2392PDF: 947HTML: 2023Fig 1 Rossi: 249 -
HIGHLIGHTS ON THE CONTRIBUTION OF GUT MICROBIOTA TO IMMUNE-MEDIATED DISEASES IN CHILDHOOD Gut microbiota in childhood immune-mediated diseases
1256PDF: 921HTML: 306 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2733PDF: 1720HTML: 2462Table1: 268 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3899PDF: 1373HTML: 2189Fig.1: 277Fig. 2: 264 -
DEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA
3300PDF: 1698HTML: 403 -
APPROACHING THE TARGET: THE PATH TOWARDS AN EFFECTIVE MALARIA VACCINE
2740PDF: 1041HTML: 15149 -
HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT
1082PDF: 573HTML: 750 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1568PDF: 1411HTML: 123 -
The association of rheumatoid arthritis with glucose- 6-phosphate dehydrogenase deficiency—results from a case-control study. G6PD and Rheumatoid Arthritis
1307PDF: 911HTML: 126 -
PEDIATRIC MASTOCYTOSIS: AN UPDATE Chldren' Mastocytosis
2170HTML: 1738PDF: 1210







